Sahil Jain

Sahil Jain grew up in India and built his career at the intersection of consumer technology and large-scale platform operations. He co-founded Dineout in 2012 alongside Ankit Mehrotra and two other close friends, scaling the restaurant discovery and booking platform from zero into India's largest dining-out technology business — processing more than 100 million diners and $800 million in transactions across 50,000 partner restaurants in 34 cities. The platform was acquired by Swiggy in 2022 for $200 million in one of India's landmark consumer-tech exits.

After the Dineout acquisition, Jain identified a new opportunity rooted in a problem he had observed firsthand: the acute gap between the NHS's capacity to deliver elective care and the appetite of UK patients to access high-quality, affordable treatment abroad. India's major hospital groups — including Fortis, Max Healthcare, and Nova IVF Fertility — offer internationally accredited care at 60 to 70 percent less than UK private rates, but the existing medical tourism market was fragmented, opaque, and devoid of the post-treatment support patients needed when they returned home.

In 2024, Jain co-founded The Medical Travel Company (TMTC) with Mehrotra to build the world's first full-stack medical travel platform. As Co-Founder and CEO, he leads the company's strategy, clinical partnerships, and patient experience infrastructure. TMTC provides UK doctor-led oversight throughout a patient's entire treatment journey in India, all-inclusive aftercare, and the world's first 12-month post-surgery insurance policy valid in the UK at a network of private hospitals.

TMTC raised $4.5 million in seed funding in October 2025, led by Nexus Venture Partners, with participation from 4CAST, the athlete-led investment collective co-founded by England cricket captain Ben Stokes and Jofra Archer. The company was named to the Forbes India DGEMS 2025 Select 200 list and plans to expand to the United States, Canada, Australia, and Europe within three to five years.